Bactericidal activity of three β-lactams alone or in combination with a β-lactamase inhibitor and two aminoglycosides against Klebsiella pneumoniae harboring extended-spectrum β-lactamases-Reference-Cited by-同舟云学术

Bactericidal activity of three β-lactams alone or in combination with a β-lactamase inhibitor and two aminoglycosides against Klebsiella pneumoniae harboring extended-spectrum β-lactamases

Published:1998-10 Issue:10 Volume:4 Page:570-576
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Roussel-Delvallez Micheline,Wallet Frédéric,Dao Anne,Marti Valérie,Sirot Danièle,Beaucaire Gilles,Courcol René

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference26 articles.

1. Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX1, a novel β-lactamase;Sirot;J Antimicrob Chemother,1987

2. Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolysing β-lactamases in a single isolate;Bradford;Antimicrob Agents Chemother,1994

3. Identification of TEM-26 β-lactamase responsible for a major outbreak of ceftazidime-resistant Klebsiella pneumoniae;Urban;Antimicrob Agents Chemother,1994

4. More extended spectrum β-lactamases;Jacoby;Antimicrob Agents Chemother,1991

5. Origin and impact of plasmid mediated extended-spectrum β-lactamases;Philippon;Eur J Clin Microbiol Infect Dis,1994

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The First Experience of Combined Use of Cefepime/Sulbactam and Aztreonam in ICU Patients with Nosocomial Infections Caused by Carbapenem-Resistant Gram-Negative Microorganisms Producing Class B and D Carbapenemases;Antibiotics and Chemotherapy;2023-02-11

2. Cefepime/Sulbactam — A New Innovative Antibiotic for In-Hospital Treatment of Severe Infections and the Implementation of Carbapenem-Replacement Strategy to Contain Antibiotic Resistance;Antibiotics and Chemotherapy;2021-06-25

3. An Open-Label, Multicenter, Observational Study of The Effectiveness of The Cefepime/Sulbactam Antibiotic (Maxictam^®-AF) In Patients With Intra Abdominal Infection, Nosocomial Pneumonia or Ventilator-Associated Pneumonia (Study MAXI-2019);Antibiotics and Chemotherapy;2021-02-13

4. Effectiveness, safety and risk of selection of carbapenem-resistant bacteria in the treatment of severe in-hospital infections with cefepime/sulbactam in comparison with carbapenems;Anesteziologiya i reanimatologiya;2020

5. Epidemiology and impact of bloodstream infections among kidney transplant recipients: A retrospective single-center experience;Transplant Infectious Disease;2018-01-19